Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism

Frontiers in Oncology

Jennifer H. Gunter¹  Marianna Kruithof-de Julio³  Eugenio Zoni⁶ 

[1] Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD, Australia;Bern Center for Precision Medicine, Inselspital, University Hospital of Bern, Bern, Switzerland;Department of Urology, Inselspital, University Hospital of Bern, Bern, Switzerland;School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia;Translational Organoid Resource, Department for BioMedical Research, University of Bern, Bern, Switzerland;Urology Research Laboratory, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland;

关键词: metabolomics;    prostate cancer;    precision medicine;    urological cancer;    bladder cancer;    kidney cancer;   

DOI  :  10.3389/fonc.2022.862811

来源: DOAJ

【 授权许可】

Unknown